Cite
HARVARD Citation
Costa, A. et al. (2022). Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet neurology. 21 (1), pp. 31-41. [Online].